DCGI and institutional ethics committee investigating claim of adverse event in COVID-19 vaccine trial: officials

A Chennai-based COVID-19 vaccine trial participant has sought a compensation of ₹5 crore and that the testing, manufacturing and distribution of the vaccine be stopped immediately

from The Hindu - Science https://ift.tt/3mlpNBB